IL17RB and ovarian cancer: As we expected, CRL4 knockdown blocked STAT3 signaling activation and reduced BIRC3 expression in ovarian cancer cells, strongly suggesting that the upregulation of BIRC3 by CRL4 was also mediated by STAT3 signaling pathway in ovarian cancer.